Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. Januar 2015 10:00 ET | Quelle: Qu Biologics;BC Cancer Agency

Qu Biologics Launches Phase 2a Clinical Trial for Non-small Cell Lung Cancer (NSCLC)

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 20, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
04. Dezember 2014 10:00 ET | Quelle: Qu Biologics

Qu Biologics Welcomes Gastroenterologist Dr. Remo Panaccione to IBD Advisory Team

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
29. Oktober 2014 09:30 ET | Quelle: Qu Biologics

Qu Biologics' Crohn's Disease Clinical Trial Completes Independent Safety Review

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 29, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
17. September 2014 10:05 ET | Quelle: Qu Biologics

Qu Biologics Closes Oversubscribed Private Funding Round of CDN$5.1 Million

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
17. Juni 2014 10:30 ET | Quelle: Qu Biologics

Qu Biologics Appoints Dr. Bob Cory as Vice President, Business Development

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 17, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
04. Juni 2014 10:00 ET | Quelle: Qu Biologics

Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived from Viruses for Treating a Range of Cancers

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 4, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
20. Mai 2014 13:07 ET | Quelle: Qu Biologics

Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Colon Cancer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 20, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
28. April 2014 14:45 ET | Quelle: Qu Biologics

Qu Biologics to Present Crohn's Disease Compassionate Use Results at Digestive Diseases Week Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
20. Februar 2014 20:49 ET | Quelle: Qu Biologics

Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 20, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...
18. Februar 2014 09:00 ET | Quelle: Qu Biologics

Qu Biologics Opens Crohn's Disease Clinical Trial to U.S. Participants

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 18, 2014) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the...

Vorherige Seite

Nächste Seite